À¶Ý®ÊÓƵ

Try our Advanced Search for more refined results

Expert Analysis

A Shifting Trend In FDA Form 483 Disclosure Obligations

By Brett Jaffe, Timothy Fitzmaurice and Sierra Shear ( August 22, 2025, 5:08 PM EDT) -- The U.S. District Court for the Southern District of New York's May 19 decision in In re: Checkpoint Therapeutics Securities Litigation extends a streak of dismissals of securities class actions alleging that pharmaceutical companies failed to disclose U.S. Food and Drug Administration Form 483 inspection reports....

À¶Ý®ÊÓƵ is on it, so you are, too.

A À¶Ý®ÊÓƵ subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A À¶Ý®ÊÓƵ subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience À¶Ý®ÊÓƵ today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies